Abiopharma

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

New Form 3 - Nano-X Imaging Ltd. Filed: 2025-09-05 AccNo: 0001507133-25-000005 Size: 5 KB

Butterfly Network, Inc. - Rutgers Robert Wood Johnson Medical School Study Published in JAMA Confirms Butterfly-Enabled POCUS Program Heavily Focused on LUNG US with AI Assistance Reduces Stay and Cost

New Form 144 - COGNEX CORP Filed: 2025-09-05 AccNo: 0002054688-25-000016 Size: 5 KB

New Form 6-K - PURPLE BIOTECH LTD. Filed: 2025-09-05 AccNo: 0001213900-25-084858 Size: 578 KB

New Form 425 - Cyclacel Pharmaceuticals, Inc. Filed: 2025-09-05 AccNo: 0001641172-25-026678 Size: 45 KB

New Form 424B5 - ARTELO BIOSCIENCES, INC. Filed: 2025-09-05 AccNo: 0001640334-25-001629 Size: 557 KB

New Form 8-K - Cyclacel Pharmaceuticals, Inc. Filed: 2025-09-05 AccNo: 0001641172-25-026676 Size: 273 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

New Form 8-K - Tharimmune, Inc. Filed: 2025-09-05 AccNo: 0001641172-25-026666 Size: 198 KB Item 8.01: Other Events

New Form 144 - DEXCOM INC Filed: 2025-09-05 AccNo: 0001959173-25-005801 Size: 4 KB

Director Pershing Edward 🟢 acquired 10.5K shares (1 derivative) of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) at $2.86 Transaction Date: Sep 04, 2025 | Filing ID: 026663

New Form PRE 14A - PALISADE BIO, INC. Filed: 2025-09-05 AccNo: 0001493152-25-012677 Size: 6 MB

Dizon Romeo R 🟢 acquired 1.1K shares of IRIDEX CORP (IRIX) at $1.39 Transaction Date: Sep 04, 2025 | Filing ID: 113167

New Form 8-K - Lipocine Inc. Filed: 2025-09-05 AccNo: 0001493152-25-012698 Size: 15 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits